FGF9 and non-small cell lung carcinoma: Recently, Rao et al. [14] found that miR-219-5p level in DDP-resistant NSCLC cells is lower than that in corresponding parental cells (A549 and SPC-A1), and that miR-219-5p may reverse NSCLC cell resistance to DDP by targeting FGF9.